<?xml version="1.0" encoding="UTF-8"?>
<p>Although there are no vaccines approved for use in the general human population, a live-attenuated vaccine created by serial passage of the TrD strain, TC-83, has been used to immunize researches working with the virus and members of the armed forces. This Investigational New Drug (IND) vaccination provides immunity to approximately 80% of the vaccinated individuals [
 <xref rid="B23-microorganisms-08-01167" ref-type="bibr">23</xref>]. However, TC-83 vaccination is also known to result in various side effects, which are usually a more mild version of the signs and symptoms caused by VEEV infection but can still be severe, including fever, headache, malaise and photophobia [
 <xref rid="B24-microorganisms-08-01167" ref-type="bibr">24</xref>]. Presently, there are no drugs or antivirals to treat VEE in humans.
</p>
